Is everybody using peptides? The answer is closer to yes than you think — and even they might not know it.
GLP-1’s are peptides, and so is insulin — to name just two of the many that are FDA-approved. Now, a handful of others are up for debate in Washington, DC..
The topic? Whether the FDA should reinstate seven peptides to the 503A Bulk Drug Substances list, which would allow compounding pharmacies to start producing them again (after they were removed three years ago). The Pharmacy Compounding Advisory Committee (PCAC) are discussing and voting on July 23 and 24, then will pass their recommendations to the FDA to make the final call.
